Clinical Trials Directory

Trials / Withdrawn

WithdrawnNCT01123122

A Comparison of Strict Glucose Control With Usual Care at the Time of Islet Cell Transplantation

Status
Withdrawn
Phase
N/A
Study type
Interventional
Enrollment
0 (actual)
Sponsor
Vancouver Coastal Health · Other Government
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Not accepted

Summary

Islet transplants for those with type 1 diabetes have enabled many to initially eliminate insulin, however, only a fraction of the transplanted cells typically survive and the functioning of these decrease over time. As a result, most patients will eventually require some insulin. Currently, the cause of this poor survival and decrease in function is not understood; although previous research has demonstrated that even a slightly elevated level of blood glucose can impair islet function. This study will determine if strict blood glucose control at the time of islet transplantation, when the cells are the most fragile, will improve the survival and functioning of transplanted islet cells three months after transplantation.

Conditions

Interventions

TypeNameDescription
OTHERStrict glucose controlBlood glucose level to be maintained at 4-6 mmol/L at the time of islet transplantation until two weeks post-transplantation.

Timeline

Start date
2011-09-01
Primary completion
2015-09-01
Completion
2015-09-01
First posted
2010-05-14
Last updated
2015-04-01

Locations

1 site across 1 country: Canada

Source: ClinicalTrials.gov record NCT01123122. Inclusion in this directory is not an endorsement.